KT&G and PMI Extend Global E-cigarette Collaboration

Jan.30.2023
KT&G and PMI Extend Global E-cigarette Collaboration
KT&G and PMI renewed a 15-year contract to sell their non-combustible products globally, helping with KT&G's overseas market position.

According to a report by Yonhap News Agency on January 30th, Korea Tobacco & Ginseng Corporation (KT&G) and Philip Morris International (PMI) have extended a supply contract for 15 years. KT&G will distribute its three types of non-burning heated products through PMI's global sales network, except in South Korea.


The products include the Lil Solid, Lil Hybrid, and Lil Aible devices, as well as their corresponding proprietary pods named Fiit, Miix, and Aiim.


During a press conference, KT&G CEO Baek Bok-in stated that this collaboration will help strengthen KT&G's position for smokeless products in international markets. The extension of the three-year strategic agreement signed with PMI in 2020 will also lay the foundation for stable growth in their global business.


KT&G Corporation recently announced during an investor event that it aims to double its sales by 2027, reaching a total of 10 trillion Korean won (approximately $8.1 billion USD). The company plans to obtain more than half of these revenues from their overseas businesses, while also strengthening their next-generation product (NGP) division, which includes heated non-burning (HnB) products and functional health foods.


According to reports, 90% of KT&G's current revenue comes from cigarette sales and the remaining 10% comes from their HnB products. The company has four tobacco manufacturing plants located in South Korea, Russia, Turkey, and Indonesia with a yearly production capacity of 13.6 billion units. Since signing an agreement with Philip Morris International in 2020, KT&G has expanded the export of their HnB products to over 30 countries.


Sources:


KT&G has set a goal of generating 50% of its sales from overseas markets by 2027.


KT&G and PMI have extended their partnership to expand their presence in global markets with e-cigarettes.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
Indonesia to Step Up Vape Surveillance as Concerns Rise Over Drug-Laced E-Cigarettes
Indonesia to Step Up Vape Surveillance as Concerns Rise Over Drug-Laced E-Cigarettes
Indonesia will strengthen surveillance of vapes amid growing concerns over drug-laced e-cigarettes. The National Food and Drug Monitoring Agency, or BPOM, will soon take charge of monitoring nationwide vape distribution and said it will work with the National Narcotics Agency, or BNN. BNN recently floated a plan to completely ban e-cigarettes, saying a total ban was the only way to prevent liquid narcotics.
May.11 by 2FIRSTS.ai
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Haypp Group reported a 40% year-on-year increase in nicotine pouch volumes in the first quarter of 2026, with U.S. and U.K. volumes rising 123% and 102%, respectively. Haypp says around 97% of its consumer traffic is organic and that its Media & Insights business provides brand owners with on-site visibility, trial activation and consumer intelligence. For international tobacco companies, Haypp may be both a growth partner for modern oral products and a new source of channel leverage.
Special Report
May.22
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI’s U.S. business released a white paper and cited a national online survey showing that 79.00% of Americans surveyed believe more should be done to reduce smoking-related harm. The paper calls on policymakers, public health authorities, and medical professionals to place cigarette smoking back at the center of public health priorities, and recommends broader access to FDA-authorized smoke-free alternatives, clearer nicotine risk communication, and risk-based taxation.
Apr.15 by 2FIRSTS.ai